Literature DB >> 14625480

Reconstituted high-density lipoprotein attenuates organ injury and adhesion molecule expression in a rodent model of endotoxic shock.

Michelle C McDonald1, Pal Dhadly, Gillian W Cockerill, Salvatore Cuzzocrea, Helder Mota-Filipe, Charles J Hinds, Norman E Miller, Christoph Thiemermann.   

Abstract

The salutary effects of high-density lipoproteins (HDLs) in animal and human models of endotoxic shock have in the past been attributed to the ability of this lipoprotein to bind to lipopolysaccharide. However, the precise mechanisms for the protective effect of HDL are unclear. The first objective of this study was to determine the effects of HDLs on the organ injury and dysfunction associated with acute severe endotoxemia. Second, to gain insight into the mechanism of action of HDL, we also investigated the effect of HDLs on 1) the expression of P-selectin and intercellular adhesion molecule-1 in the kidneys of rats treated with endotoxin and 2) the rise in the plasma levels of tumor necrosis factor-alpha (TNF-alpha). Rats were given Escherichia coli lipopolysaccharide (6 mg/kg i.v.), pretreated with either vehicle (n = 9) or reconstituted HDL (rHDL; apolipoprotein A-I/phosphatidylcholine proteoliposomes, n = 10), and were monitored for 6 h. Here we report that rHDL attenuates the renal injury and dysfunction caused by endotoxin in the rat. In addition, rHDL reduced the degree of histological tissue injury in the lung, liver and intestine and attenuated the expression of P-selectin and intercellular adhesion molecule-1 in the renal glomerulus. Interestingly, pretreatment of rats with rHDL did not prevent the hypotension nor the rise in plasma levels of TNF-alpha (at 90 min) caused by endotoxin. Thus, rHDL reduces the organ injury/dysfunction, but does not affect the circulatory failure, nor the rise in plasma levels of TNF-alpha caused by endotoxin in the rat. We propose that the mechanisms of these beneficial effects of HDL may be related to direct inhibition of adhesion molecule expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14625480     DOI: 10.1097/01.shk.0000097249.97298.a3

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  32 in total

1.  Lysophosphatidylcholine reduces the organ injury and dysfunction in rodent models of gram-negative and gram-positive shock.

Authors:  Oliver Murch; Marika Collin; Bruno Sepodes; Simon J Foster; Helder Mota-Filipe; Christoph Thiemermann
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

Review 2.  New insights into the role of HDL as an anti-inflammatory agent in the prevention of cardiovascular disease.

Authors:  Philip J Barter; Rajesh Puranik; Kerry-Anne Rye
Journal:  Curr Cardiol Rep       Date:  2007-11       Impact factor: 2.931

3.  Changes in HDL-associated apolipoproteins relate to mortality in human sepsis and correlate to monocyte and platelet activation.

Authors:  Stefan Barlage; Carsten Gnewuch; Gerhard Liebisch; Zsuzsanna Wolf; Franz-Xaver Audebert; Thomas Glück; Dieter Fröhlich; Bernhard K Krämer; Gregor Rothe; Gerd Schmitz
Journal:  Intensive Care Med       Date:  2009-08-08       Impact factor: 17.440

Review 4.  Lipoproteins in inflammation and sepsis. II. Clinical aspects.

Authors:  Martina Wendel; Rüdiger Paul; Axel R Heller
Journal:  Intensive Care Med       Date:  2006-11-09       Impact factor: 17.440

Review 5.  Lipoproteins in inflammation and sepsis. I. Basic science.

Authors:  Oliver Murch; Marika Collin; Charles J Hinds; Christoph Thiemermann
Journal:  Intensive Care Med       Date:  2006-11-09       Impact factor: 17.440

6.  Deletion of scavenger receptor A gene in mice resulted in protection from septic shock and modulation of TLR4 signaling in isolated peritoneal macrophages.

Authors:  Robert Drummond; David M Cauvi; Dennis Hawisher; Donghuan Song; Diego F Niño; Raul Coimbra; Stephen Bickler; Antonio De Maio
Journal:  Innate Immun       Date:  2012-07-02       Impact factor: 2.680

Review 7.  Modifying the anti-inflammatory effects of high-density lipoprotein.

Authors:  Benjamin J Ansell; Gregg C Fonarow; Mohamad Navab; Alan M Fogelman
Journal:  Curr Atheroscler Rep       Date:  2007-01       Impact factor: 5.113

Review 8.  HDL and endothelial protection.

Authors:  A Tran-Dinh; D Diallo; S Delbosc; L Maria Varela-Perez; Q B Dang; B Lapergue; E Burillo; J B Michel; A Levoye; J L Martin-Ventura; O Meilhac
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

9.  Increased expression of CD14 in macrophages after inhibition of the cholesterol biosynthetic pathway by lovastatin.

Authors:  Tiffany Frey; Antonio De Maio
Journal:  Mol Med       Date:  2007 Nov-Dec       Impact factor: 6.354

10.  L-4F inhibits lipopolysaccharide-mediated activation of primary human neutrophils.

Authors:  Oleg F Sharifov; Xin Xu; Amit Gaggar; Edlue M Tabengwa; C Roger White; Mayakonda N Palgunachari; G M Anantharamaiah; Himanshu Gupta
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.